Novel neuropeptide Y receptor antagonists block vasoconstriction in the hamster cheek pouch microcirculation.
We investigated the efficacy of novel neuropeptide Y (NPY) antagonists to inhibit the microcirculatory dynamics of NPY in the hamster cheek pouch microcirculation using intravital microscopy and computer-assisted image analysis. Changes in arteriolar diameter served as an index of vasomotor alterations. Fluorescein isothiocyanate-labeled Dextran 150 served as a tracer for measurements of macromolecular transport. GW 383 and GW 1229, two novel NPY receptor antagonists, were applied topically in separate experiments. Pretreatment with 10(-5), 10(-6) and 10(-7) M GW 383 and with 10(-6) and 10(-8) M GW 1229 attenuated the vasoconstriction induced by 10(-7) M NPY in a dose-dependent manner. Furthermore, pretreatment with 10(-7) and 10(-8) M GW 1229 significantly inhibited the 10(-9) M NPY-induced vasoconstriction. At these doses, the NPY antagonists did not alter microvascular permeability. Our results demonstrate that the novel NPY antagonists inhibit the vasoconstriction induced by NPY in the hamster check pouch microcirculation. We suggest that the inhibition is due to binding of antagonists to Y1-type NPY receptors.
Kim
D
D
Department of Pharmacology and Physiology, UMDNJ-New Jersey Medical School, Newark 07103-2714, USA.
Durán
W T
WT
Daniels
A J
AJ
Durán
W N
WN
D000818:Animals; D001160:Arterioles / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D002199:Capillary Permeability / Q000187:drug effects; D002610:Cheek / Q000098:blood supply; D006224:Cricetinae; D006400:Hematocrit; D008297:Male; D008647:Mesocricetus; D008833:Microcirculation / Q000187:drug effects; D009842:Oligopeptides / Q000494:pharmacology*; D017476:Receptors, Neuropeptide Y / Q000037:antagonists & inhibitors*; D014665:Vasodilator Agents / Q000494:pharmacology*
C105058:GW 1229; D009842:Oligopeptides; D017476:Receptors, Neuropeptide Y; D014665:Vasodilator Agents